Abstract
We assessed the use of magnesium sulphate prior to preterm birth for preventing cerebral palsy in an Australian and New Zealand registry study. Use increased markedly from 32.3% (2012) to 78.8% (2020) (p < 0.001). Binational approaches to sustain and explore the feasibility of further increasing use, informed by evolving evidence and guidelines, are needed.
| Original language | English |
|---|---|
| Number of pages | 5 |
| Journal | Australian and New Zealand Journal of Obstetrics and Gynaecology |
| DOIs | |
| Publication status | E-pub ahead of print - 16 Jan 2025 |
| Externally published | Yes |
Keywords
- cerebral palsy
- guideline adherence
- infant
- magnesium sulphate
- premature
- premature birth